4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000033
Chief Financial Officer gave up 1,927 shares (to pay taxes)
- Chief Financial Officer acquired 5,893 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hirsch Andrew · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-04-22 | Exercise or conversion : show line 1 in the form | +5,893 | 26,199 | D | ||
| 2020-04-22 | Shares withheld for taxes : show line 2 in the form | −1,927 | $45.91 | $88,469 | 24,272 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-04-22 | Exercise or conversion : show line 3 in the form Restricted stock units | −5,893 | 11,785 | D |
Loading xslF345X03/wf-form4_158775877429935.xml…